Caudate and hippocampal volume differences in patients with schizophrenia are associated with disease and antipsychotic treatment, but local shape alterations have not been thoroughly examined. Schizophrenia patients randomly assigned to haloperidol and olanzapine treatment underwent magnetic resonance imaging (MRI) at 3, 6, and 12 months. The caudate and hippocampus were represented as medial representations (M-reps); mesh structures derived from automatic segmentations of high resolution MRIs. Two quantitative shape measures were examined: local width and local deformation. A novel nonparametric statistical method, adjusted exponentially tilted (ET) likelihood, was used to compare the shape measures across the three groups while controlling for covariates. Longitudinal shape change was not observed in the hippocampus or caudate when the treatment groups and controls were examined in a global analysis, nor when the three groups were examined individually. Both baseline and repeated measures analysis showed differences in local caudate and hippocampal size between patients and controls, while no consistent differences were shown between treatment groups. Regionally specific differences in local hippocampal and caudate shape are present in schizophrenic patients. Treatment-related related longitudinal shape change was not observed within the studied timeframe. Our results provide additional evidence for disrupted cortico-basal gangliathalamo-cortical circuits in schizophrenia. Clinical trial information: This longitudinal study was conducted from
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Introduction
Converging trends in the neuroimaging of schizophrenia have led to the research conducted in this study. The first trend is the association of altered caudate volume with antipsychotic treatment. Reduction in caudate volume has been reported in magnetic resonance imaging (MRI) studies of antipsychotic-naïve, first-episode schizophrenia patients (Corson et al., 1999a; Keshavan et al., 1998; Levitt et al., 2002; Shihabuddin et al., 1998) , who should not exhibit effects associated with treatment and disease chronicity; however, findings are inconsistent (Chakos et al., 1994; Gur et al., 1998a) . Cross-sectional MRI studies suggest that treatment of schizophrenia with typical antipsychotic medications can be, but is not always, associated with enlarged caudate. Dose (Chakos et al., 1994) and treatment findings (Corson et al., 1999b; Keshavan et al., 1994; Lieberman et al., 2005; Massana et al., 2005) have been observed over periods of 12-24 months in Bad end-of-line word break: lon-gitu-di-nal MRI studies. Treatment of schizophrenia with atypical antipsychotics for extended periods is associated with decreases in caudate volume (Corson et al., 1999b) , although studies in rodents are not entirely consistent with the human data (Andersson et al., 2002; Lee et al., 1999) .
The second trend is the reduction of volume (McClure and Weinberger, 2001 ) and deformation of shape (Csernansky et al., 1998 (Csernansky et al., , 2002 
